title: Phase I study of taxol in refractory acute myelogenous leukemias using a weekly schedule.
authors.affiliation: University of Texas, M.D. Anderson Cancer Center, Department of Hematology, Houston, USA. munker@gsf.de
authors.forename: R
authors.initials: R
authors.lastname: Munker
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
authors.forename: S
authors.initials: S
authors.lastname: O'Brien
authors.forename: M
authors.initials: M
authors.lastname: Keating
authors.forename: M
authors.initials: M
authors.lastname: Andreeff
authors.forename: E H
authors.initials: EH
authors.lastname: Estey
mesh_terms: D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage*
chemical_list: D017239:Paclitaxel